Adenozinski A1 receptor (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Adenozinski A1 receptor" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

8nih.gov

4^th place

3^rd place

7doi.org

2^nd place

1ahajournals.org

3,608^th place

1,651^st place

1archive.org

6^th place

5^th place

ahajournals.org

circ.ahajournals.org

Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT (March 2002). „BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy”. Circulation 105 (11): 1348–53. DOI:10.1161/hc1102.105264. PMID 11901047.

archive.org

Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT (August 2007). „Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study”. Journal of the American College of Cardiology 50 (7): 600–6. DOI:10.1016/j.jacc.2007.03.059. PMID 17692744.

doi.org

dx.doi.org

Townsend-Nicholson A, Baker E, Schofield PR, Sutherland GR (1995). „Localization of the adenosine A₁ receptor subtype gene (ADORA1) to chromosome 1q32.1”. Genomics 26 (2): 423–5. DOI:10.1016/0888-7543(95)80236-F. PMID 7601478.
Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, Basheer R, Haas HL, Zilles K, Bauer A (2007). „Sleep deprivation increases A₁ adenosine receptor binding in the human brain: a positron emission tomography study”. J. Neurosci. 27 (9): 2410–5. DOI:10.1523/JNEUROSCI.5066-06.2007. PMID 17329439.
Tawfik HE, Schnermann J, Oldenburg PJ, Mustafa SJ (2005). „Role of A₁ adenosine receptors in regulation of vascular tone”. Am. J. Physiol. Heart Circ. Physiol. 288 (3): H1411–6. DOI:10.1152/ajpheart.00684.2004. PMID 15539423.
Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT (March 2002). „BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy”. Circulation 105 (11): 1348–53. DOI:10.1161/hc1102.105264. PMID 11901047.
Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT (August 2007). „Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study”. Journal of the American College of Cardiology 50 (7): 600–6. DOI:10.1016/j.jacc.2007.03.059. PMID 17692744.
Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC (October 2007). „The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance”. Journal of the American College of Cardiology 50 (16): 1551–60. DOI:10.1016/j.jacc.2007.07.019. PMID 17936154.
Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM (October 2008). „The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment”. Journal of Cardiac Failure 14 (8): 631–40. DOI:10.1016/j.cardfail.2008.08.010. PMID 18926433.

nih.gov

ncbi.nlm.nih.gov

Townsend-Nicholson A, Baker E, Schofield PR, Sutherland GR (1995). „Localization of the adenosine A₁ receptor subtype gene (ADORA1) to chromosome 1q32.1”. Genomics 26 (2): 423–5. DOI:10.1016/0888-7543(95)80236-F. PMID 7601478.
Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, Basheer R, Haas HL, Zilles K, Bauer A (2007). „Sleep deprivation increases A₁ adenosine receptor binding in the human brain: a positron emission tomography study”. J. Neurosci. 27 (9): 2410–5. DOI:10.1523/JNEUROSCI.5066-06.2007. PMID 17329439.
Tawfik HE, Schnermann J, Oldenburg PJ, Mustafa SJ (2005). „Role of A₁ adenosine receptors in regulation of vascular tone”. Am. J. Physiol. Heart Circ. Physiol. 288 (3): H1411–6. DOI:10.1152/ajpheart.00684.2004. PMID 15539423.
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (December 2001). „International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors”. Pharmacol. Rev. 53 (4): 527–52. PMID 11734617.
Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT (March 2002). „BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy”. Circulation 105 (11): 1348–53. DOI:10.1161/hc1102.105264. PMID 11901047.
Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT (August 2007). „Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study”. Journal of the American College of Cardiology 50 (7): 600–6. DOI:10.1016/j.jacc.2007.03.059. PMID 17692744.
Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC (October 2007). „The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance”. Journal of the American College of Cardiology 50 (16): 1551–60. DOI:10.1016/j.jacc.2007.07.019. PMID 17936154.
Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM (October 2008). „The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment”. Journal of Cardiac Failure 14 (8): 631–40. DOI:10.1016/j.cardfail.2008.08.010. PMID 18926433.